Aroclor 1254 inhibits anti-inflammatory macrophage polarization through an AhR-dependent mechanism
Behan-Bush RM., Kilburg E., Liszewski JN., Schrodt MV., Sander EA., Klingelhutz AJ.
Laboratory Study on Chronic Inflammation, published in J Endocr Soc (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Endocr Soc (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41541288
- PMCID
- PMC12801039
- DOI
- 10.1210/jendso/bvaf205
Abstract (original English)
Macrophages are critical regulators of tissue homeostasis and inflammation. During the development of chronic inflammatory diseases, tissue-resident macrophages often shift from an anti-inflammatory (M2) to a pro-inflammatory (M1) phenotype. Understanding the factors that drive this polarization shift is essential for elucidating the mechanisms underlying diseases such as cancer, cardiovascular disease, and metabolic syndrome. Environmental toxicants, including polychlorinated biphenyls (PCBs), may be key contributors to this dysregulation. Despite being banned in the United States for nearly 50 years, PCBs persist in the built and natural environment, with mixtures such as Aroclor 1254 still detected at concerning levels in schools and other public spaces. In this study, we investigated how Aroclor 1254 influences human monocyte-derived macrophage polarization. We found that exposure to Aroclor 1254 during differentiation skews naïve macrophages toward a pro-inflammatory phenotype, enhances LPS/IFNγ-driven M1 polarization, and inhibits both IL-4- and dexamethasone-induced M2 polarization. To explore underlying mechanisms, we examined the roles of peroxisome proliferator-activated receptor gamma (PPARγ), pyruvate kinase M2 (PKM2), and the aryl hydrocarbon receptor (AhR). We found AhR inhibition partially rescued PCB-mediated suppression of M2 polarization. Further supporting th
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol